Skip to main content
Premium Trial:

Request an Annual Quote

Deltagen Appoints interim CEO; ChrondoGene Adds Member to SAB; and Others

NEW YORK, April 4 -- Joseph Limber has been appointed interim CEO of Deltagen, the company said today, and will move on to be president and CEO as soon as Deltagen closes an equity financing.


Limber was president and CEO of Aclara BioSciences until 2002. Prior to that, he was president and COO at Praecis Pharmaceuticals. He also held senior business development and sales and marketing positions with Sequus Pharmaceuticals, Syntex, and Ciba-Geigy.

Frank Barry has been appointed to the scientific advisory board of ChondroGene, the company said today.


Barry is the director for arthritis research at Osiris Therapeutics. He has held teaching positions at a variety of institutions, including the University College Cork, the University of South Florida College of Medicine, and JohnsHopkinsUniversity.

Jim Bull has become head of North American sales of New Milton, UK-based Genetix Group, the company said March 31.


Most recently, Bull was director of sales at GeneMachines. Prior to that, he held sales and marketing positions at Molecular Dynamics, later Amersham Pharmacia Biotech, including those of product manager and director of North American sales.

Baron Frederick Charles von Nidda has been named general manager of Applied DNA Sciences, the company said March 31.


Von Nidda, a partner in the European-advisory firm GA Associates, has recently helped with the finance and expansion of a number of independent businesses, including the engineering firm Minimould, the pharma company Res-Del International, the medical firm Clinical Research Centres International; and the media concern Tri-Continental Films.

The UK Biobank has appointed John Newton as CEO.


Newtonhas been the consultant epidemiologist at the Department of Public Health and Primary Care at Oxfordfor eleven years, and was also director of R&D at the Oxford Radcliffe Hospitals NHS Trust.

Brian Ritchie, formerly CEO and president of Blackstone Computing (most recently Argentys) has joined storage consulting services firm GlassHouse Technologies as senior vice president of sales.



The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.